An Observational Study to Assess Change in Disease Activity and Treatment Patterns of Upadacitinib When Given Alone or Co-Administered With Methotrexate in Adult Participants With Active Psoriatic Arthritis
Clinical trial NCT05616871 · COMPLETED
Trial details
- NCT number
- NCT05616871
- Sponsor
- AbbVie
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2022-12-15
- Primary completion
- 2026-06-11
- Enrollment
- 464
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.